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Atypical clinical presentation of an Arthroderma gypseum 
infection in a renal transplant recipient 
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ABSTRACT
Dermatophytes are known as a common cause of superficial mycosis, but atypical 
presentations in immunosuppressed patients make the diagnosis more challenging. Here, we 
report a case of a 39-year-old patient, a renal transplant recipient from a living donor, who 
presented with atypical cutaneous lesions of lower extremities caused by Arthroderma gypseum 
(Nannizzia gypsea), four months after receiving a renal transplant. It is important to highlight the 
importance of the early detection of fungal infections in immunosuppressed patients. Clinicians 
should have a high degree of suspicion for the early detection and treatment of the cases. 
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INTRODUCTION
Superficial fungal infections caused by dermatophytes affect 20 to 25% of the 
world population. The predominant causative species vary geographically and 
commonly include Trichophyton, Arthroderma and Epidermophyton ssp. Fungal 
elements are generally restricted to the corneal layer of the epidermis, producing 
typical lesions with erythema and scaling. 
However, in patients undergoing solid organ transplantation, skin lesions are 
frequent and due to the immunosuppression they are submitted to. Oliveira et al.1 
evaluated 177 patients who underwent solid organ transplantation, having found 147 
(83%) with skin lesions, 107 (60%) with infections, 30% with common warts and 28 
(16%) with superficial mycoses, onychomycosis being the most frequent, followed by 
extensive scaling lesions in the inguinal region, abdomen and trunk in 9% of cases, 
the majority being caused by Trichophyton rubrum. Another study2 carried out on 223 
patients undergoing organ transplantation, found 108 cases (46%) of superficial fungal 
infections, with the oral cavity most frequently affected by Candida albicans, followed 
by mycosis of the nails, inguinal region, abdomen and trunk by Trichophyton sp.
However, in transplant recipients, atypical forms of fungal infection are described 
in the literature, underlining the need for a differential diagnosis with other diseases 
and even with deep mycosis3. Although atypical lesions caused by dermatophytes 
such as Trycophyton rubrum and Microsporum canis4,5 have already been reported 
in the literature, to the best of our knowledge ,there is no report on Arthroderma 
gypseum (Nannizzia gypsea) as a cause of deep mycosis in a renal transplant 
recipient, mimicking hyalohyphomycosis.
CASE REPORT
A 39-year-old female patient presented with pruritic erythematous papules 
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on the right side of the ankle, four months after receiving 
a renal transplant. At this time, the patient was using 
azathioprine 150 mg orally daily, cyclosporine 250 mg 
orally twice a day and prednisone 40 mg orally daily. The 
patient reported having a controlled high blood pressure 
and did not report a previous or present history of other 
comorbidities. The lesions increased in size and spread 
bilaterally to both lower extremities. Subsequently, they 
progressed to ulcerated plaques with a blood-draining s 
discharge (Figure 1).
The confirmation of deep mycosis by M. gypseum 
(N. gypsea) was made through a direct mycological 
examination, culture in Agar Sabouraud (Figure 2) and a 
cutaneous biopsy, however, the molecular identification 
of the strain was not performed. The histopathology 
demonstrated acanthosis and spongiosis of epidermis, 
a granulomatous and suppurative intense inflammation 
of the dermis and hypodermis (Figure 3) along with the 
presence of fungal septate hyphae in Grocott’ staining 
(Figure 4).
The treatment with oral Itraconazole (100 mg per day) 
was carried out for two months, however, due to its potential 
kidney injury, it was replaced by terbinafine (250 mg per 
day) for more three months. The cutaneous lesions improved 
with progressive healing, eventually leading to multiple 
violaceous nodules on both lower extremities.
Figure 1 - Erythematous and violaceous papules and nodules, 
some of them with exulcerated surface on the limbs.
Figure 2 – Microculture showing macroconidia of Arthroderma 
gypseum and Macroculture on Agar Sabouraud displaying the 
Arthroderma gypseum growth. 
Figure 3 – Top image: intense mixed inflammatory infiltrate with 
suppuration in the dermis and the hypodermis. HE, OM: x 40 
magnification; Bottom image: granulomatous and suppurative 
inflammation with epithelioid and giant multinucleated histiocytes 
and neutrophils in the dermis. HE, OM: x 400 magnification.
Figure 4 - Histopathology: Grocott’s staining disclosing fungal 
hyphae in the dermis. OM: x 400 magnification.
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DISCUSSION
Dermatophytes generally cause cutaneous superficial 
mycosis by invading dead keratinized tissue, as 
dermatophytes are highly specialized parasites of keratinized 
layers of the skin, but under certain conditions, are capable 
of living and multiplying in the dermis and/or subcutis, as 
was observed in our patient6. Their hyphae penetrate the 
stratum corneum and hair and cause mechanical damage 
to the skin and hair followed by secondary inflammation 
and immune response. Furthermore, less commonly, the 
infection of dermis and hypodermis can occur as an extent 
of the disease in the presence of intense inflammation and 
rupture of the hair follicle, with subsequent granulomatous 
reaction seen in the histopathological analysis. Cell 
mediated immunity and delayed hypersensitivity reaction 
acting as a protective mechanism, contribute to the clinical 
picture of the dermatophyte infection. These lesions 
are mostly found on the lower limbs of female patients 
caused by Tricophyton rubrum3,5. Arthroderma gypseum 
(Nannizzia gypsea) is a geophilic fungus and its natural 
habitat is the soil. The diagnosis is usually based on history, 
clinical examination, direct microscopy, fungal culture and 
histopathological examination.
Invasive diseases due to dermatophytes are frequently 
associated with chronic superficial dermatophytosis 
as well as other factors such as the use of topical 
corticosteroids, atopic skin conditions and indwelling 
catheters7. Immunocompromised patients have an increased 
incidence of dermatophyte infections, are more prone to 
relapses and chronic infections, and are at risk for invasive 
disease7. In transplant recipients on immunosuppressive 
medications, superficial dermatophyte infections are more 
common than the usual in immune compromised patients.
In fact, most of the reports described extensive 
lesions caused by different sorts of fungi8,9. Reviewing 
the current literature, we found only two clinical cases 
similar to our case, caused by Arthroderma gypseum10,11 
in immunosuppressed patients, making our clinical case 
unusual from a scientific point of view.
Furthermore, the most similar condition in comparison 
with ours is Wilson’s granulomatous nodular perifolliculitis 
on the legs, considered a variation of Majocchi’s granuloma, 
described by Wilson et al.12 in 1954, but caused by 
T. rubrum. Moreover, there are three well-described 
forms of invasive dermatophyte infections: Majocchi’s 
granuloma, a deeper dermal dermatophytosis, and a 
disseminated dermatophytosis7. The indolent form is known 
as Majocchi’s granuloma, which may be subclassified into 
two types: (i) a fungal suppurative folliculitis, observed 
in healthy subjects due to hair follicular invasion, often 
in immunocompetent patients, and (ii) the second type 
of Majocchi’s granuloma, often referred to as a nodular 
granulomatous perifolliculitis, that is a deeper lesion found 
in immunocompromised patients and usually exhibits a 
greater burden of fungal organisms in the lesion7. In the 
last type, patients can develop several lesions, as well 
described by Lestringant et al.13 that treated the patients with 
immunosuppressant drug therapies for a non-Hodking’s 
lymphoma and they developed a sudden outbreak of more 
than 100 subcutaneous nodules without granulomatous 
reaction.
Follicular dermatophyte infections of the dermis in 
immunocompetent patients usually occur in women after 
shaving their legs in a backward movement and inoculating 
fungal elements into the dermis12. As in our clinical case, 
the deep dermal and subcutaneous nodular form in an 
immunosuppressed patient is characterized by three phases: 
the first one is similar to Tinea corporis infections, with 
erythematous scaly plaques and pruritic border, progressing 
to the second phase with bigger painful violaceous nodules 
tending to ulcerate and characterizing the third phase, called 
the degenerative phase12,14.
These firm or floating nodules are more commonly 
described on the legs, but they can also appear on the scalp, 
hands etc.14. Such lesions often resemble a deep bacterial 
pyoderma. Other comorbidities such as malnutrition, 
leukemia, lymphomas or immunosuppressive therapies 
may also affect the action of polymorphonuclear cells and 
macrophages, that constitute the defense against dermophyte 
dermal invasion14. However, the fact that dermatophytes 
rarely penetrate below the epidermis when patients have 
very low CD4 T cell numbers, for example in HIV-positive 
individuals, and inhibition of immune responses through 
the development of an ineffective TH2 response in common 
chronic infections suggest that the survival of viable fungi 
in the dermis or lymphatics, or the dissemination through 
the bloodstream seldom occurs despite the underlying 
reduced immune capacity, as observed in our patient15. To 
prove this observation, in experimental murine infections, 
ablation of this T-cell pathway leads to chronic, extensive, 
but not internally disseminated infections16. 
Uncommon invasive subacute or chronic dermatophyte 
infections were reported by Araviysky et al.17, who found 
a deep infiltration of skin and subcutaneous tissues, 
lesions of lymph nodes, bones and cartilages, viscera and 
central nervous system, and these authors claimed that the 
characteristic features of a deep generalized granulomatous 
trichophytosis should be considered. Allen et al.18 described 
a 15-year old girl who developed a tinea corporis due 
to Microsporum audouinii associated with energy and 
defective lymphocyte transformation as a consequence 
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of a deficiency of an uncharacterized plasma factor, 
who developed a rapidly progressive left hemiparesis, 
generalized hyperreflexia and virtually total body surface 
involvement with erythematous, scaly, crusted and fissured 
plaques, and she finally recovered after a total dose of 
1,500 mg of amphotericin B.
Considering the rising number of immunosuppressed 
patients due to medications, infections or malignancies, 
physicians should be aware of the presence of atypical 
infections caused by dermophytes that can mimic bacterial 
infections, especially in immunocompromised subjects. 
We highlight the need to adopt a low threshold to perform 
a biopsy of papules, nodules or plaques with prolonged 
evolution, which are resistant to therapy.
Deep dermatophyte infections are a challenge 
in dermatological practice, both for their insight in 
diagnosis and management. Early and proper diagnosis 
decreases the risk of the infection dissemination among 
immunosuppressed patients and the subsequent morbidities. 
The early onset of the treatment with the combination of 
topical azoles and oral antifungals need to be considered 
for the management of these patients. 
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